Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau® Pro
Full
Celyad Oncology Reports Full Year 2020 Financial Results and Recent Business Highlights
No safety concerns or evidence of Graft-versus-Host disease reported from first dose cohort of Phase
Kronos Bio Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
Positive End-of-Phase 2 meeting with the FDA for entospletinib in newly diagnosed NPM1-mutated acute myeloid
XpresSpa Team to Present Company Update and Announce Fourth Quarter and Full Calendar year 2020 Financial Success on March 31
Bloomberg U.S. Companies Shell out Penalties to Refinance as Inflation Fears Loom (Bloomberg) — U.S.
SELLAS Life Sciences Reports Full Year 2020 Financial Results and Provides Business Update
Entered into Exclusive License Agreement, with $7.5 Million Upfront License Fee and Potential to Receive
Newtek Business Services Corp. Reports Full Year 2020 Financial Results
BOCA RATON, Fla., March 22, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (“Newtek” or
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
FDA Type C meeting communications support plans to initiate Phase 2 in Q2 with NM-002
VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Tuesday, March 23 at 8:00
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company
Ocugen Provides Business Update and Full Year 2020 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy